M&A Deal Summary

Exact Sciences Acquires Ashion Analytics

On February 16, 2021, Exact Sciences acquired life science company Ashion Analytics from TGen

Acquisition Highlights
  • This is Exact Sciences’ 5th transaction in the Life Science sector.
  • This is Exact Sciences’ 6th transaction in the United States.
  • This is Exact Sciences’ 3rd transaction in Arizona.

M&A Deal Summary
Date 2021-02-16
Target Ashion Analytics
Sector Life Science
Buyer(s) Exact Sciences
Sellers(s) TGen
Deal Type Divestiture

Target

Ashion Analytics

Phoenix, Arizona, United States
Ashion Analytics is a clinical genomics testing company dedicated to accelerating the use of genomic information to help doctors provide patients with the right treatment for their disease. Ashion Analytics LLC was founded in 2014 and is based in Phoenix, Arizona.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Exact Sciences

Madison, Wisconsin, United States
Category Company
Founded 1995
Sector Life Science
Employees6,500
Revenue 2.5B USD (2023)
DESCRIPTION

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

DEAL STATS #
Overall 7 of 8
Sector (Life Science) 5 of 6
Type (Divestiture) 1 of 1
State (Arizona) 3 of 3
Country (United States) 6 of 7
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-27 Thrive Earlier Detection

Cambridge, Massachusetts, United States

Thrive Earlier Detection Corp. is a healthcare company focused on incorporating earlier cancer detection into routine medical care to extend and save lives. Thrive is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of the disease. CancerSEEK will serve as the core of Thrive's integrated cancer information offering. Thrive Earlier Detection Corp. was formed in 2019 and is based in Cambridge, Massachusetts.

Buy $2.2B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-09 PreventionGenetics

Marshfield, Wisconsin, United States

PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. PreventionGenetics was founded in 2004 and is based in Marshfield, Wisconsin.

Buy $190M

Seller(S) 1

SELLER

TGen

Phoenix, Arizona, United States
Category Company
Founded 2002
Sector Life Science
DESCRIPTION

TGen is a nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. TGen focused on developing earlier diagnoses and smarter treatments. Translational genomics research employs innovative advances arising from the Human Genome Project by applying them to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. TGen was founded in 2002 and is based in Phoenix, Arizona.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Arizona) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal